Effects of Insulin-Like Growth Factors (IGFs) and IGF Receptor Antibodies on the Proliferation of Human Breast Cancer Cells

References

• Cassella S. J., Han V. K., D'Ercole A. J., Svovoda M. E., Van Wyk J. J. Insulin‐like growth factor II binding to the type I somatomedin receptor. J. Biol. Chem. 1986; 261: 9268–9273
   PubMedGoogle Scholar
• Conover C. A., Misra P., Hintz R. L., Rosenfeld R. G. Effect of an anti‐insulin‐like growth factor receptor antibody on insulin‐like growth factor II stimulation of DNA synthesis in human fibroblasts. Biochem. Biophys. Res. Commun. 1986; 139: 501–508
   PubMedGoogle Scholar
• Cullen K. J., Yee D., Sly W., Perdue J., Hampton B., Lipp‐man M. E., Rosen N. Insulin‐like growth factor receptor expression and function in human breast cancer. Cancer Research 1990; 50: 48–53
   PubMed Web of Science ®Google Scholar
• Daughaday W. H. Editorial: The possible Autocrine/Paracrine and Endocrine roles of insulin‐like growth factors of human tumors. Endocrinol. 1990; 127(1)1–4
   PubMed Web of Science ®Google Scholar
• De Leon D. D., Bakker B., Wilson D. M., Hintz R. L., Rosenfeld R. G. Demonstration of insulin‐like growth factor (IGF‐I and ‐II) receptors and binding proteins in human breast cancer cell lines. Biochem. Biophys. Res. Comm. 1988; 152: 398–405
   PubMed Web of Science ®Google Scholar
• Furlanetto R. W., Di Carlo J. N., Wisehart C. The type II insulin‐like growth factor receptor does not mediate deoxyribonucleic acid synthesis in human fibroblasts. J. Clin. Endocrinol. Metab. 1987; 67: 669–675
   Google Scholar
• Humbel R. E. Insulin like growth factors I and II. Eur. J. Biochem. 1990; 190: 445–462
   PubMedGoogle Scholar
• Karey K. P., Sibarsku D. A. Differential responsiveness of human breast cancer cell line MCF‐7 and T‐47D to growth factors and 17B‐estradiol. Cancer Res. 1988; 48: 4083–4092
   PubMed Web of Science ®Google Scholar
• Kiess W., Thomas C. T., Greenstein L. A., Lee L., Sklar M. M., Rechler M. W., Sahagian G. G., Nissley S. P. Insulin‐like growth factor‐II (IGF‐II) inhibits both the cellular uptake of β‐gal to purified IGF‐II/mannose‐6‐phosphate receptor. J. Biol. Biochem. 1989; 264(8)4710–4714
   Google Scholar
• Kiess W., Thomas C. L., Sklar M. M., Nissley S. P. B‐Galactosidase decreases the binding affinity of the insulin‐like growth factor‐II/mannose‐6‐phosphate receptor for insulin‐like growth‐factor‐II. Eur. J. Biochem. 1990; 190: 71–77
   PubMedGoogle Scholar
• Kull F. C., Jacobs S., Su Y. F., Svoboda M. E., Van Wyk J. J., Cuatrecasas P. Monoclonal antibodies to receptor for insulin and somatomedin C. J. Biol. Chem. 1983; 258: 6561–6566
   PubMed Web of Science ®Google Scholar
• Mathieu M., Rochefort H., Barenton B., Prebois C., Vig‐non F. Interactions of cathespin‐D and insulin‐like growth factor‐II (IGF‐II) on the IGF‐II/mannose‐6‐phos‐phatase receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF‐II. Mol. Endocrinol. 1990; 4(9)1327–1335
   PubMedGoogle Scholar
• Morgan D. O., Roth R. A. Identification of a monoclonal antibody which can distinguish between two distinct species of the type I receptor for the insulin‐like growth factor. Biochem. Biophys. Res. Commun. 1986; 138: 1341–1347
   PubMedGoogle Scholar
• Nolan C. M., Creek K. E., Grubb J. H., Sly W. S. Antibody to the phosphomannosyl receptor inhibits recycling of receptor in fibroblasts. J. Cell Biochem. 1987; 35: 137–151
   PubMedGoogle Scholar
• Ogasawara M., Sibarsku D. A. A new serum‐free method of measuring growth factor activities for human breast cancer cells in culture. In Vitro Cell and Dev. Biol. 1988; 9: 911–920
   Google Scholar
• Osborne C. K., Coronado E. B., Kitten L. J., Arteaga C. I., Fuqua S. A. W., Ramasharma K., Marshall M., Li C. H. Insulin‐like growth factor‐II (IGF‐II): A potential autocrine/paracrine growth factor for human breast cancer acting via the IGF‐I receptor. Mol. Endocrinol. 1989; 3(11)1701–1709
   PubMedGoogle Scholar
• Pfeffer S. R. The endosomal concentration of a man‐nose 6‐phosphate receptor is unchanged in the absence of ligand synthesis. J. Cell Biol. 1987; 105: 229–234
   PubMedGoogle Scholar
• Rechler M. M., Nissley S. P. Insulin‐like growth factor. Handbook of Experimental Pharmacology, M. B. Sporn, A. B. Roberts. Springer‐Verlag, BerlinGermany 1990; 95: 263–367, (1)
   Google Scholar
• Roth R. A., Steele‐Perkins G., Hari J., Stover C., Pierce S., Turner J., Edman J. C., Rutter W. J. Insulin and insulin‐like growth factor receptors and responses. Cold Spring Harbor Symposia on Quantitative Biology 1988; V(LIII)537–543
   Google Scholar
• Steele‐Perkins G., Turner J., Edman J. C., Hari J., Pierce S. B., Stover C., Rutter W. J., Roth R. A. Expression and characterization of a functional human insulin‐like growth factor receptor. J. Biol. Chem. 1988; 263(23)11486–11492
   PubMedGoogle Scholar
• Steele‐Perkins G., Roth R. A. Monoclonal antibody αIR3 inhibits the ability of Insulin‐like growth factor‐II to stimulate a signal from the type‐1 receptor without inhibiting its binding. Biochem. Biophys. Res. Commun. 1990; 171(3)1244–1251
   PubMedGoogle Scholar
• Yee D., Cullen K. J., Paik S., Perdue J. F., Hampton B., Schwartz A., Lippman M. E., Rosen N. Insulinlike growth factor II mRNA expression in human breast cancer. Cancer Research 1988; 48: 6991–6996
   Google Scholar
• Yee D., Paik S., Lebovic G., Marcus R., Favoni R., Cullen K., Lippman M. E., Rosen N. Analysis of IGF‐I gene expression in malignancy—evidence for a paracrine role in human breast cancer. Mol. Endocrinol. 1989; 3: 509–517
   PubMed Web of Science ®Google Scholar